Merck Sharp & Dohme Corp
- View government funding actions
- Kenilworth, NJ 070331310
- Phone: 215-652-7621
- Estimated Number of Employees: 44,673
- Estimated Annual Receipts: $4,061,000,000
- Business Start Date: 1934
- Contact Person: Joseph Denshaw
- Contact Phone: 215-652-7091
- Contact Email: joseph_denshaw@merck.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Manufacturer of Goods
- Industries Served: Pharmaceutical Preparation Manufacturing, Biological Product (except Diagnostic) Manufacturing
- Product Areas: DRUGS AND BIOLOGICALS
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $7,146 - Monday the 23rd of July 2012
Department Of Navy
US NAVAL HOSPITAL OKINAWA
ZOSTAVAX VARICELLA DS SDV 10X0.65ML - $7,119 - Tuesday the 18th of September 2012
Department Of Navy
U S NAVAL HOSPITAL GUAM
NDC: 00006-4827-00, YF-VAX - $7,119 - Sunday the 1st of July 2012
Department Of Navy
U S NAVAL HOSPITAL GUAM
NDC: 00006-4827-00, VARIVAX VACCINES - $7,119 - Tuesday the 31st of July 2012
Department Of Navy
U S NAVAL HOSPITAL GUAM
NDC: 00006-4827-00, VARIVAX VACCINES - $6,119 - Monday the 18th of April 2016
Office Of Assistant Secretary For Administration
PHA CO, PHS, SSC, PERRY POINT MD
VARICELLA VACCINE - $6,119 - Wednesday the 15th of August 2012
Department Of Navy
NAVAL HOSPITAL PENSACOLA FL
VARIVAX VACCINE W/ DILUENT - $5,741 - Saturday the 29th of September 2012
Veterans Affairs Department
69D-NETWORK CONTRACT OFFICE 12
ZOSTER VACCINE - $5,741 - Monday the 10th of September 2012
Veterans Affairs Department
69D-NETWORK CONTRACT OFFICE 12
ZOSTER - $48,355 - Monday the 18th of April 2016
Office Of Assistant Secretary For Administration
PHA CO, PHS, SSC, PERRY POINT MD
VACCINES - $30,306 - Tuesday the 11th of September 2012
Department Of Navy
NAVAL HOSPITAL PENSACOLA FL
VACCINE
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.